Health TrialsbyHealthPanel

Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D?

ConditionsDiabetes MellitusErectile DysfunctionVitamin D Deficiency
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age35-45
SponsorCairo University

About this trial

males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

diabetic men (forty)

type 2 diabetes

complaint of erectile dysfucntion (chronic complaint more than 24 months)

men with low vitamin D (deiciency in vitamin D)

Disqualifiers

cardiac patients

respiratory disease patients

renal disease

liver disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • exercise and vitamin D intake

    Behavioral

    twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.

  • vitamin D intake

    Other intervention

    twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: group number 1Experimental treatment 1 intervention
Group B: group number 2Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

international index of erectile function

questionnaire used to assess impotence

Time frame
it will be measured after 12 weeks

Secondary outcomes

1

glycated hemoglubin

it will be used to assess blood glcuose

Time frame
It will be measured after 12 weeks
2

fasting blood glcuose

it will be used to assess blood glcuose in serum

Time frame
It will be measured after 12 weeks
3

body mass index

it will be measured on empty stomach and bladder

Time frame
It will be measured after 12 weeks
4

wasit circumference

it will be measured at umbilicus level

Time frame
it will be measured after 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Cairo University

Lead sponsor

Source ClinicalTrials.gov
Apply now